Building resilience after lymphoma treatment
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study tests a program to help people who recently finished treatment for lymphoma build resilience and cope with the challenges of survivorship. It uses telehealth so you can join from home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You speak English
- It has been at least 6 months since your lymphoma diagnosis
- You finished your active treatment (like chemo or radiation) within the last 2 years
- You do not have a serious mental health or memory condition that would make it hard to participate
- You can use video or phone appointments (telehealth)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help lymphoma survivors improve their long-term quality of life by building resilience after finishing treatment. It is designed for people who have completed active treatment for lymphoma within the last two years.
This trial tests a telerehabilitation (remote exercise/rehab) program for people with recent lymphoma or other blood cancers after chemotherapy. It aims to improve recovery and fitness while monitoring safety through an exercise test and check-ins.
This trial tests a virtual (online) rehabilitation and exercise program for people after breast, colorectal, head and neck, or certain blood cancers. It may help improve recovery and daily functioning by supporting safe activity and targeted rehab after treatment.
This study explores how integrative medicine (such as nutrition, mind-body practices, or supplements) might help people recover and improve well-being after finishing lymphoma treatment. It is for patients who are in remission for less than one year.
This trial tests a home-based rehabilitation program using phone or video sessions to help people with lymphoma or myeloma recover better after CAR-T cell therapy. It aims to improve physical function and quality of life during treatment.
This study tests whether a structured health education and “older adult care” approach—done with your oncology team—can improve support for people after cancer. It includes older cancer survivors and a chosen caregiver, using in-person or video visits for follow-up.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.